Roles of IL-8 in Ocular Inflammations: A Review

被引:136
作者
Ghasemi, Hassan [1 ]
Ghazanfari, Tooba
Yaraee, Roya
Faghihzadeh, Soghrat [2 ]
Hassan, Zuhair Mohammad [2 ]
机构
[1] Shahed Univ, Sch Med, Dept Ophthalmol, Immunoregulat Res Ctr, Tehran, Iran
[2] Tarbiat Modares Univ, Tehran, Iran
关键词
angiogenesis; chemokine; cytokine; interleukine-8; ocular inflammation; HUMAN INTERLEUKIN-8 RECEPTOR; ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; PROLIFERATIVE DIABETIC-RETINOPATHY; CORNEAL EPITHELIAL-CELLS; GENE-EXPRESSION; CYTOKINE LEVELS; AQUEOUS-HUMOR; INTRAVITREAL BEVACIZUMAB; STAPHYLOCOCCUS-AUREUS;
D O I
10.3109/09273948.2011.618902
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Introduction: This review presents the current in vitro and in vivo animal and human research on the roles of IL-8 in ocular inflammatory diseases. Materials and Methods: Data sources were a literature review using Pub Med, Medline, and ISI databases (from 1990 to 2011). Search items included interleukine-8 (IL-8), CXCL8, chemokines, cytokines, alone or in combination with the, serum, aqueous, vitreous, eye, ocular, ocular tissues, ophthalmic, and review. Results: IL-8 may be involved in primary or secondary ocular inflammations. Ocular effects of IL-8 differ based on the source of the secretion and site of the action. The most important effects of IL-8 in the eyes are angiogenic activities and induction of ocular inflammation. Conclusion: IL-8 plays important roles in ocular inflammation and angiogenesis in conjunctiva, cornea, iris, retina, and orbit. Anti-IL-8 targeted immunotherapy has been introduced as an important treatment modality, provided that IL-8 signal blocking takes place in desired areas and tissues.
引用
收藏
页码:401 / 412
页数:12
相关论文
共 132 条
  • [1] CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis
    Abu El-Asrar, Ahmed M.
    Al-Obeidan, Saleh S.
    Kangave, Dustan
    Geboes, Karel
    Opdenakker, Ghislain
    Van Damme, Jo
    Struyf, Sofie
    [J]. IMMUNOBIOLOGY, 2011, 216 (09) : 1004 - 1009
  • [2] The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity
    Addison, CL
    Daniel, TO
    Burdick, MD
    Liu, H
    Ehlert, JE
    Xue, YY
    Buechi, L
    Walz, A
    Richmond, A
    Strieter, RM
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (09) : 5269 - 5277
  • [3] The CXC chemokines growth-regulated oncogene (GRO) alpha, GRO beta, GRO gamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor
    Ahuja, SK
    Murphy, PM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) : 20545 - 20550
  • [4] Role of interleukin 8 in the pathogenesis of proliferative vitreoretinopathy
    Aksunger, A
    Or, M
    Okur, H
    Hasanreisoglu, B
    Akbatur, H
    [J]. OPHTHALMOLOGICA, 1997, 211 (04) : 223 - 225
  • [5] Angiostatin anti-angiogenesis requires IL-12: The innate immune system as a key target
    Albini, Adriana
    Brigati, Claudio
    Ventura, Agostina
    Lorusso, Girieca
    Pinter, Marta
    Morini, Monica
    Mancino, Alessandra
    Sica, Antonio
    Noonan, Douglas M.
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2009, 7
  • [6] A comparison between cultivated and conventional limbal stem cell transplantation for Stevens-Johnson syndrome
    Ang, Leonard P. K.
    Sotozono, Chie
    Koizumi, Noriko
    Suzuki, Tomo
    Inatomi, Tsutomu
    Kinoshita, Shigeru
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (01) : 178 - 180
  • [7] Apostolakis S, 2006, INT J MOL MED, V17, P691
  • [8] Interleukin 8 and cardiovascular disease
    Apostolakis, Stavros
    Vogiatzi, Konstantina
    Amanatidou, Virginia
    Spandidos, Demetrios A.
    [J]. CARDIOVASCULAR RESEARCH, 2009, 84 (03) : 353 - 360
  • [9] Detection of neutrophils and possible involvement of interleukin-8 in diffuse lamellar keratitis after laser in situ keratomileusis
    Asano-Kato, N
    Toda, I
    Shimmura, S
    Noda-Tsuruya, T
    Fukagawa, K
    Yoshinaga, M
    Matsukawa, A
    Tsubota, K
    [J]. JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2003, 29 (10) : 1996 - 2000
  • [10] Atta-ur-Rahman, 1999, CURR PHARM DESIGN, V5, P241